Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Grimmer

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Genes & Development|March 19, 2008
BMPs oppose Math1 in cerebellar development and in medulloblastomaMatthew R Grimmer, William A Weiss
Epigenomics|November 29, 2014
Can genome engineering be used to target cancer-associated enhancers?Matthew R Grimmer, Peggy J Farnham
Current Opinion in Pediatrics|November 14, 2006
Childhood tumors of the nervous system as disorders of normal developmentMatthew R Grimmer, William A Weiss
Nature|December 25, 2015
Cancer: Oncogene brought into the loopMatthew R Grimmer, Joseph F Costello
Nucleic Acids Research|August 15, 2014
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulationMatthew R Grimmer, Sabine Stolzenburg, Ethan Ford, et al.
Neuro-Oncology|February 17, 2018
Temozolomide-associated hypermutation in gliomasSerah Choi, Yao Yu, Matthew R Grimmer, et al.
Nucleic Acids Research|January 9, 2016
Effects on the transcriptome upon deletion of a distal element cannot be predicted by the size of the H3K27Ac peak in human cellsYu Gyoung Tak, Yuli Hung, Lijing Yao, et al.
Genome Biology|July 26, 2022
Large-scale manipulation of promoter DNA methylation reveals context-specific transcriptional responses and stabilityAlex de Mendoza, Trung Viet Nguyen, Ethan Ford, et al.
Neuro-Oncology Advances|September 9, 2020
Patient-derived cells from recurrent tumors that model the evolution of <i>IDH</i>-mutant gliomaLindsey E Jones, Stephanie Hilz, Matthew R Grimmer, et al.
Cancer Cell|May 26, 2012
Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYCFredrik J Swartling, Vasil Savov, Anders I Persson, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Genes & Development|March 19, 2008
BMPs oppose Math1 in cerebellar development and in medulloblastomaMatthew R Grimmer, William A Weiss
Epigenomics|November 29, 2014
Can genome engineering be used to target cancer-associated enhancers?Matthew R Grimmer, Peggy J Farnham
Current Opinion in Pediatrics|November 14, 2006
Childhood tumors of the nervous system as disorders of normal developmentMatthew R Grimmer, William A Weiss
Nature|December 25, 2015
Cancer: Oncogene brought into the loopMatthew R Grimmer, Joseph F Costello
Nucleic Acids Research|August 15, 2014
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulationMatthew R Grimmer, Sabine Stolzenburg, Ethan Ford, et al.
Neuro-Oncology|February 17, 2018
Temozolomide-associated hypermutation in gliomasSerah Choi, Yao Yu, Matthew R Grimmer, et al.
Nucleic Acids Research|January 9, 2016
Effects on the transcriptome upon deletion of a distal element cannot be predicted by the size of the H3K27Ac peak in human cellsYu Gyoung Tak, Yuli Hung, Lijing Yao, et al.
Genome Biology|July 26, 2022
Large-scale manipulation of promoter DNA methylation reveals context-specific transcriptional responses and stabilityAlex de Mendoza, Trung Viet Nguyen, Ethan Ford, et al.
Neuro-Oncology Advances|September 9, 2020
Patient-derived cells from recurrent tumors that model the evolution of <i>IDH</i>-mutant gliomaLindsey E Jones, Stephanie Hilz, Matthew R Grimmer, et al.
Cancer Cell|May 26, 2012
Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYCFredrik J Swartling, Vasil Savov, Anders I Persson, et al.
Pageof 2